Clicky

FRESENIUS SE+CO. ADR 1/4(FREA)

Description: Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.


Keywords: Autoimmune Disease Cell Therapy Healthcare Facilities Dialysis Operational Management Apheresis Parenteral Nutrition Fresenius Kidney Dialysis Chronic Kidney Failure Related Disposable Products Bad Homburg Vor Der Höhe Dialysis Related Services Parenteral Nutrition Products

Home Page: www.fresenius.com

Else-Kroener-Strasse 1
Bad Homburg vor der Höhe, 61352
Germany
Phone: 49 6172 6080


Officers

Name Title
Mr. Michael Sen CEO, President & Chairman of Management Board of Fresenius Management SE
Ms. Sara Lisa Hennicken CFO & Member of the Management Board - Fresenius Management SE
Mr. Pierluigi Antonelli Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi
Dr. Michael Sven Moser Ph.D. Member of Management Board of Fresenius Management SE
Mr. Robert Moller Member of the Management Board of Fresenius Management SE
Mr. Nick Stone Senior VP of Investor Relations & Head of Investor Relations - Fresenius Management SE
Matthias Link Senior Vice President Corporate Communications
Sebastian Schlagwein Head of Group ESG

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 9.434
Trailing PE: 39.5238
Price-to-Book MRQ: 0.9932
Price-to-Sales TTM: 0.8388
IPO Date:
Fiscal Year End: December
Full Time Employees: 177091
Back to stocks